MedPath

Development and Evaluation of a Web Based Decision Aid for Patients With Hip Osteoarthritis

Not Applicable
Completed
Conditions
Osteoarthritis
Hip Osteoarthritis
Interventions
Other: Patient Decision Aid (PtDA)
Other: Brochure with general information about osteoarthritis
Registration Number
NCT04241978
Lead Sponsor
Servicio Canario de Salud
Brief Summary

The main goal of this study is assess the effectiveness of a PtDA for patients with hip osteoarthritis

Detailed Description

Background: Osteoarthritis (OA) is a health condition sensitive to patient's preferences and values regarding the benefits and risks of the different treatment options. In this sense, patient decision aids (PtDA) can play an important role in helping patients to incorporate their values, needs and preferences into the decision-making process, thus improving Person-Centred Care (PCC). Previous research has focused almost exclusively on knee OA, and therefore the aim of this study is to develop and evaluate the effectiveness of a PtDA for patients with hip OA.

Methods: The general design consists of two phases: 1) design a web-based PtDA for patients with hip OA, following the recommended procedures: systematic review of safety/effectiveness of treatments, and an iterative process of development with the help of an Advisory Committee composed of health professionals and patients; 2) To evaluate the impact of the PtDA on hip OA patients' decision-making process related with their treatment. For that aim, a multicenter randomized controlled trial will be carried out with 124 patients with hip OA in Tenerife (Spain) comparing intervention or usual care.

Discussion: PtDAs have been recommended as a useful and effective resource for improving PCC in many health conditions. The intervention is intended to empower patients by fostering their active participation during the decision-making process about their treatment, and by ensuring they make informed decisions congruent with their values and preferences. This study will contribute to the scientific knowledge about effectiveness of PtDAs in hip OA, in order to improve the quality of health care offered to these patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
130
Inclusion Criteria
  • Patients with diagnosis of hip Osteoarthritis
Exclusion Criteria
  • Patients younger than 18 years
  • Previous hip arthroplasty
  • Patients with terminal illnesses
  • Non-fluent Spanish language
  • Mental or sensory alterations that impede or hinder the response to the measurement instruments or do not have the capacity to make decisions.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupPatient Decision Aid (PtDA)The participants will complete the baseline assessment and will be asked to read the project information sheet. Then, patients allocated to the intervention group will review the PtDA accompanied by the researcher and will complete the questionnaires assessing the outcome measures, in the same web interface.
Control groupBrochure with general information about osteoarthritisPatients in the control group will follow the same procedure, but they will be given a brochure with general information about osteoarthritis of the hip, knee, ankle and foot instead of the PtDA
Primary Outcome Measures
NameTimeMethod
Decisional conflict regarding the treatment for Hip Osteoarthritis, measured by the Decisional Conflict Scale (DCS)Immediately after the intervention

DCS is a 16-item self-reported scale widely used in PtDA research. It is composed of five subscales: uninformed, values, support, uncertainty and effectiveness. This is a 0-100 point scale, where a high score means more decisional conflict.

Secondary Outcome Measures
NameTimeMethod
Decision quality about arthroplastyImmediately after the intervention

Binary variable (yes/no) defined as a combination of adequate knowledge (≥60% of correct responses) and concordance.

Treatment preferenceImmediately after the intervention

Patients will be asked the treatment they prefer: physiotherapy, medication, intra-articular injections, arthroplasty, not sure

Knowledge of the disease and treatmentsBefore and immediately after the intervention

A 7-item scale will be udes to assess patients' knowledge of the disease and treatments

Intention to undergo the preferred treatmentImmediately after the intervention

Assessed with one item ranging 0 (not sure) to 5 (completely sure)

Satisfaction with the decision making process scaleImmediately after the intervention

The Satisfaction with Decision Scale (SWD) is a validated 12-item scale measuring participants' satisfaction with healthcare decision making. The SWD uses a 5-point Likert scale where 0 is "Strongly Disagree" and 4 is "Strongly Agree." This is a 0-100 point scale, where a high score means more satisfaction with the decision making process.

Values about characteristics of treatmentsImmediately after the intervention

Patients will be asked to rate in a 0-10 scale the importance they attribute to different characteristics of treatment: mode of administration, improvement in pain and function, risk of mild and serious adverse effects, time until symptoms' improvement, duration of benefits, and in the case of arthroplasty, period of rehabilitation and risk of needing surgery revision.

Concordance between values and intention to undergo arthroplasty vs. conservative treatmentsImmediately after the intervention

Binary variable (yes/no) derived from the association between values and intention to undergo arthroplasty (see statistical analysis).

Trial Locations

Locations (1)

Evaluation Unit. Canary Islands Health Service

🇪🇸

Santa Cruz De Tenerife, Santa Cruz Tenerife, Spain

© Copyright 2025. All Rights Reserved by MedPath